Watchlist Price Alert

Lexicon Pharmaceuticals I... (LXRX)

NASDAQ: LXRX · Real-Time Price · USD

0.66

-0.01 (-1.71%)

At close: Jun 16, 2025, 3:59 PM

0.66

-1.22%

After-hours: Jun 16, 2025, 07:41 PM EDT

Lexicon Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	31.08M	1.2M	139K	298K	24M	322.07M	63.21M	90.33M	83.34M
Cost of Revenue	616K	85K	427K	55.05M	1.93M	3.23M	2.49M	1.9M	163.97M
Gross Profit	30.46M	1.12M	-288K	-54.75M	22.07M	318.84M	60.72M	88.44M	-80.64M
Operating Income	-197.12M	-171.75M	-100.76M	-87.09M	-178.78M	141.44M	-103.28M	-136.68M	-137.16M
Interest Income	12.29M	7.73M	1.6M	134K	2.77M	3.35M	3.51M	1.95M	2.29M
Pretax Income	-200.4M	-177.12M	-101.94M	-87.76M	-58.57M	124.12M	-120.55M	-141.71M	-141.43M
Net Income	-200.4M	-177.12M	-103.13M	-88.27M	-70.18M	130.13M	-120.55M	-129.05M	-141.43M
Selling & General & Admin	143.1M	113.98M	48.08M	32.34M	47.23M	56.84M	63.75M	66.2M	43.04M
Research & Development	84.48M	58.89M	52.82M	55.05M	153.62M	91.92M	100.24M	156.81M	178.15M
Other Expenses	n/a	n/a	n/a	n/a	1.6M	28.64M	n/a	1.95M	2.29M
Operating Expenses	227.58M	172.87M	100.9M	87.39M	200.85M	148.76M	164M	223.02M	221.19M
Interest Expense	15.58M	13.1M	2.78M	802K	14.54M	20.68M	20.78M	6.98M	6.57M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	228.2M	172.95M	100.9M	87.39M	202.78M	151.99M	166.49M	224.91M	221.19M
Income Tax Expense	n/a	n/a	1.18M	510K	11.61M	-6.01M	3.51M	-12.66M	4.51M
Shares Outstanding (Basic)	320.03M	221.13M	165.73M	145.65M	110.84M	106.22M	105.74M	105.12M	103.86M
Shares Outstanding (Diluted)	320.03M	221.13M	165.73M	145.65M	110.84M	116.75M	105.83M	105.24M	103.86M
EPS (Basic)	-0.63	-0.8	-0.62	-0.61	-0.63	1.23	-1.14	-1.23	-1.36
EPS (Diluted)	-0.63	-0.8	-0.62	-0.61	-0.63	1.11	-1.14	-1.23	-1.36
EBITDA	-184.29M	-163.46M	-98.74M	-86.66M	-41.1M	173.74M	-96.09M	-125.27M	-125.82M
EBIT	-184.82M	-164.02M	-99.16M	-86.96M	-44.03M	170.08M	-99.77M	-128.67M	-124.88M
Depreciation & Amortization	534K	554K	427K	292K	2.93M	3.65M	3.68M	3.4M	2.06M